Loading
institutionsInstitution
University of Florida Health Cancer Center
Florida's newest NCI-designated centre (2023), with a pioneering proton institute in Jacksonville and personalised mRNA vaccine work in brain tumours.
Also called: UF Health Cancer Institute
Overview
UF Health Cancer Center received NCI designation in 2023 and covers north-central Florida from Gainesville. The UF Health Proton Therapy Institute in Jacksonville, opened in 2006, was among the first US proton centres and has treated large numbers of paediatric and prostate patients. Duane Mitchell and Elias Sayour's neuro-oncology immunotherapy programme developed RNA-loaded dendritic cell vaccines and, in 2024, reported a personalised mRNA-lipid particle vaccine that rapidly reprogrammed the immune response in glioblastoma patients. The centre also hosts a large paediatric oncology programme and rural community outreach.
Location
Gainesville, FL, US
Type
cancer center · University of Florida
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
clinical
OnCo score
#147 · 34 points (0 Newsweek + 8 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to UF Health Cancer Center, including child institutions. 103 works · 1,601 citations · 67% open access · 23% clinical trials · 1% reviews.
Oncology works per year
192022
342023
232024
212025
62026
Most works
- Thomas J. George36 works
- Greg Yothers15 works
- Ji‐Hyun Lee12 works
- Norman Wolmark10 works
- Jesus C. Fabregas9 works
- Qian Shi9 works
- David L. DeRemer9 works
- Eileen M. O’Reilly9 works
- Jeffrey A. Meyerhardt8 works
- Sherise C. Rogers8 works
Most cited
- Proton therapy (Jacksonville)
- Brain tumour immunotherapy and mRNA vaccines
- Paediatric oncology
Similar pages
- Key paperOutcome of ivermectin in cancer treatment: an experience in Loja, Ecuador
Shares ICONIC: ivermectin combined with immune checkpoint inhibition in cancer (University of Florida phase 2), Ivermectin.
- InstitutionO'Neal Comprehensive Cancer Center at UAB
Shares NCI-Designated Cancer Centers, Proton therapy, National Cancer Institute (NIH), Glioma & glioblastoma.
- InstitutionUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
- InstitutionThe University of Kansas Cancer Center
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
- InstitutionRobert H. Lurie Comprehensive Cancer Center of Northwestern University
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, The brain: barrier and sanctuary, Proton therapy, National Cancer Institute (NIH).
- InstitutionMayo Clinic Comprehensive Cancer Center in Arizona
Shares NCI-Designated Cancer Centers, Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, National Cancer Institute (NIH).
- Key paperIvermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer (with 2026 expression of concern)
Shares ICONIC: ivermectin combined with immune checkpoint inhibition in cancer (University of Florida phase 2), Ivermectin.
- Key paperThe threat of medical misinformation: a case of ivermectin toxicity in a pediatric oncology patient
Shares ICONIC: ivermectin combined with immune checkpoint inhibition in cancer (University of Florida phase 2), Ivermectin.
cancers
fronts
technologies
drugs
Phase 2Oral antiparasitic small molecule (macrocyclic lactone), studied in cancer as an add-on to checkpoint antibodies
Ivermectin · Stromectol